Peringkat dalam Saham
#40643
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Harga Saham
$0.00323826
Terakhir disinkronkan: 2026-08-12
Kapitalisasi Pasar
$104.81K
Perubahan (1 tahun)
-70.42%
Perdagangan Purple Biotech Ltd. (PPBT)
Harga PPBT dengan kapitalisasi pasar B
Kapitalisasi pasar dari Purple Biotech Ltd.(PPBT)
Kapitalisasi Pasar: $104.81K
Per August 2026, Purple Biotech Ltd. memiliki kapitalisasi pasar sebesar $104.81K. Ini menjadikan Purple Biotech Ltd. sebagai perusahaan 40643rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Purple Biotech Ltd. dari 2002 hingga 2026
PPBT dibandingkan dengan 5 teratas stocks paling populer
| Harga PPBT |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.466T
|
+5,215,023,849.19%
|
|
|
|
|
$4.456T
|
+4,251,622,723.86%
|
|
|
|
|
$4.175T
|
+3,983,159,796.26%
|
|
|
|
|
$3.688T
|
+3,518,595,960.56%
|
|
|
|
|
$2.865T
|
+2,733,230,024.17%
|
